AutoNation, Quest: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Advanced Micro (AMD)rated new Hold at Jefferies. $7.50 price target. Company has attractive growth prospects, but a vacuum in the CEO position.

Ametek (AME) rated new Neutral at UBS. $47 price target. Valuation near full at present prices.

AutoNation (AN) downgraded at Wells from Market Perform to Underperform. New vehicle sales have been lower across the industry in May and June.

Avery Dennison (AVY) downgraded at Baird from Outperform to Neutral. $39 price target. Disappointing 2Q pre-announcement and related lowering of FY11 expectations.

Check Point Software (CHKP) upgraded at BofA/Merrill from Neutral to Buy. Estimates also boosted. $71 price target.

Carlisle Companies (CSL) upgraded at FBR from Underperform to Market Perform, FBR Capital Markets said. $45 price target. Commercial construction market is improving and raw materials costs have pulled back.

Quest Diagnostics (DGX) downgraded at Jefferies from Buy to Hold. $64 price target. Healthcare services could remain under pressure, as unemployment figures remain high.

Edwards Lifesciences (EW) rated new Neutral at Credit Suisse. Valuation call, based on a $99 price target.

Fusion-io (FIO) rated new Outperform at Credit Suisse. $40 price target. Company is leveraged to continued demand from datacenters.

Fusion-io (FIO) rated new Neutral at JP Morgan. Valuation call, based on a $35 price target.

Hershey Foods (HSY) rated new Neutral at Ticonderoga Securities. Valuation call, as the stock is pricing in market share gains.

IDEX Corp. (IEX) upgraded at UBS from Neutral to Buy. $52 price target. Pullback offers attractive entry point.

Intel (INTC) rated new Hold at Jefferies. $25 price target. Company is leveraged to decelerating PC demand.

Kellogg (K) rated new Neutral at Ticonderoga. Company is in the midst of an earnings transition.

Nuvasive (NUVA) upgraded at Baird from Neutral to Outperform. $42 price target. Spine market has likely bottomed out.

Scotts Miracle-Gro (SMG) downgraded at BMO to Market Perform. $50 price target. MAT28 is facing increased scrutiny.

Thoratec (THOR) rated new Outperform at Credit Suisse. $43 price target. Company can continue to grow its market share across the globe.

Texas Instruments (TXN) rated new Buy at Jefferies. $38 price target. NSM purchase should allow the company to grow within the analog market.

VCA Antech (WOOF) upgraded at BofA/Merrill from Underperform to Buy. $28 price target. Recent acquisitions should help augment growth.



End of report.

This article was written by a staff member of TheStreet.